Literature DB >> 20248470

Di-iso propylfluorophosphonate (DFP) its pharmacology and its therapeutic uses in glaucoma and myasthenia gravis.

J P QUILLIAM.   

Abstract

Entities:  

Keywords:  GLAUCOMA/therapy; MYASTHENIA/gravis

Mesh：

Substances：

Year:  1947        PMID： 20248470      PMCID： PMC2529536          DOI： 10.1136/pgmj.23.260.280

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  4 in total

1.  The permeability of the blood-aqueous humour barrier to potassium, sodium, and chloride in the surviving eye.

Authors:  H Davson; J P Quilliam
Journal:  J Physiol       Date:  1940-05-14       Impact factor: 5.182

2.  The paralysis of involuntary muscle: Part III. On the action of pilocarpine, physostigmine, and atropine upon the paralysed iris.

Authors:  H K Anderson
Journal:  J Physiol       Date:  1905-12-30       Impact factor: 5.182

3.  SOME OBSERVATIONS ON THE PRESENT POSITION OF OUR KNOWLEDGE OF THE INTRA-OCULAR FLUID.

Authors:  S Duke-Elder; J C Quilliam; H Davson
Journal:  Br J Ophthalmol       Date:  1940-09       Impact factor: 4.638

4.  ZONE BEHAVIOR OF ENZYMES : ILLUSTRATED BY THE EFFECT OF DISSOCIATION CONSTANT AND DILUTION ON THE SYSTEM CHOLINESTERASE-PHYSOSTIGMINE.

Authors:  O H Straus; A Goldstein
Journal:  J Gen Physiol       Date:  1943-07-20       Impact factor: 4.086
  4 in total
  1 in total

Review 1.  Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs.

Authors:  Rona R Ramsay; Keith F Tipton
Journal:  Molecules       Date:  2017-07-15       Impact factor: 4.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.